Naren Ramakrishna is an Oncology physician affiliated with University of Central Florida. OpenAlex indexes 99 publications with 3,153 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NovocureProgram year20253 paymentsResearch
- Novocure Inc.Program year20251 payment
- Brainlab, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
62.3%Corticosteroid62.3%Dexamethasone100%Part D≥22 patientsNervous system
37.7%N-methyl-D-aspartate Receptor Antagonist37.7%Memantine Hcl100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tumor Treating Fields Therapy After Stereotactic Radiosurgery for Brain Metastases From Non-Small Cell Lung Cancer: Final Results of the Phase 3 METIS Study
International Journal of Radiation Oncology*Biology*Physics
2025 - Evaluating Carbon Footprint of Proton Therapy Based on Power Consumption and Possible Mitigation Strategies
International Journal of Radiation Oncology*Biology*Physics
2023 - Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
Journal of Clinical Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Tolentino, MD
University of Central Florida
Iswanto Sucandy, MD
University of Central Florida
Omar Faour, MD
University of Central Florida
Nina Tsakadze, MD
University of Central Florida
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”